trial

Contingency Management of Psychostimulant Abuse in the Severely Mentally Ill

NCTId NCT00809770
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 176 (actual)
Sponsored by University of Washington
Primary completion 2012-07
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
176 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2008-04
Primary completion
2012-07
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Contingency management

Sponsors

University of WashingtonLead Sponsor
National Institute on Drug Abuse (NIDA)Collaborator

Investigators

1
Richard K Ries, MDPrincipal Investigator

Sites

1 total
Seattle, United States

Facts & assertions

4 sourced
Enrollment
176
Phase
NA
Primary Completion Date
2012-07
Status
COMPLETED
relationships
The graph out of here
drug
Contingency management
drug
lead_sponsor
University of Washington
company
collaborator
National Institute on Drug Abuse (NIDA)
company
indication
Bipolar Disorder
indication
Major Depressive Disorder
indication
Depressive Disorder, Major
indication
investigator
Richard K Ries, MD
person